Standard BioTools
LAB
LAB
66 hedge funds and large institutions have $89.1M invested in Standard BioTools in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 25 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 15
53% less call options, than puts
Call options by funds: $29K | Put options by funds: $62K
56% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 25
Holders
66
Holding in Top 10
2
Calls
$29K
Puts
$62K
Top Buyers
| 1 | +$4.06M | |
| 2 | +$2.32M | |
| 3 | +$558K | |
| 4 |
SAM
Silverback Asset Management
Chapel Hill,
North Carolina
|
+$96.5K |
| 5 |
MCP
Mirador Capital Partners
Pleasanton,
California
|
+$92.6K |
Top Sellers
| 1 | -$2.46M | |
| 2 | -$1.61M | |
| 3 | -$629K | |
| 4 |
D.E. Shaw & Co
New York
|
-$457K |
| 5 |
Jane Street
New York
|
-$431K |